Table 1.
PSMC2 staining and clinicopathological characteristics of 220 HCC patients.
| Variables | PSMC2 staining | |||||||
|---|---|---|---|---|---|---|---|---|
| Low (%) | High (%) | Total | P* | |||||
| Age | ||||||||
| ≤55 | 87 (78.3) | 24 (21.6) | 111 | 0.309 | ||||
| >55 | 79 (72.4) | 30 (27.5) | 109 | |||||
| Sex | ||||||||
| Male | 105 (70.5) | 44 (29.5) | 149 | 0.013 | ||||
| Female | 61 (85.9) | 10 (14.1) | 71 | |||||
| Preoperative AFP (ng/mL) | ||||||||
| ≤20 | 60 (72.3) | 23 (27.7) | 83 | 0.333 | ||||
| >20 | 90 (78.3) | 25 (21.7) | 115 | |||||
| ALT(U/L) | ||||||||
| ≤40 | 92 (75.5) | 30 (24.5) | 122 | 0.983 | ||||
| >40 | 67 (75.3) | 22 (24.7) | 89 | |||||
| Liver cirrhosis | ||||||||
| Yes | 111 (73.0) | 41 (27.0) | 152 | 0.211 | ||||
| No | 55 (80.8) | 13 (19.2) | 68 | |||||
| Tumor size (cm) | ||||||||
| ≤5 | 112 (82.4) | 24 (17.6) | 136 | 0.002 | ||||
| >5 | 54 (64.3) | 30 (35.7) | 84 | |||||
| Tumor number | ||||||||
| Single | 146 (75.2) | 48 (24.8) | 194 | 0.978 | ||||
| Multiple | 18 (75.0) | 6 (25.0) | 24 | |||||
| TNM | ||||||||
| I | 52 (74.2) | 18 (25.8) | 70 | 0.781 | ||||
| II/III | 111 (76.1) | 35 (23.9) | 146 | |||||
| Differentiation | ||||||||
| I/II | 98 (78.4) | 27 (21.6) | 125 | 0.388 | ||||
| III/IV | 63 (73.3) | 23 (26.7) | 86 | |||||
| Tumor recurrence | ||||||||
| Yes | 92 (74.8) | 31 (25.2) | 123 | 0.428 | ||||
| No | 59 (79.8) | 15 (20.2) | 74 | |||||
*
P values are from χ2 test. The bold values are considered as statistically significant.
Some cases were not available for the information.